Rituximab as salvage therapy for refractory chronic GVHD

Bone Marrow Transplant. 2008 May;41(10):909-11. doi: 10.1038/bmt.2008.12. Epub 2008 Feb 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Chronic Disease
  • Female
  • Graft vs Host Disease / drug therapy*
  • Hematologic Neoplasms / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Rituximab
  • Salvage Therapy / methods*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab